Dr. Min-li Cary, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2027 Suffolk Rd Ste 4, Finksburg, MD 21048 Phone: 410-526-1055 |
Dr. Margaret Munsell Roberts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2025 Suffolk Rd, Finksburg, MD 21048 Phone: 410-526-1055 Fax: 410-526-5211 |
Lionel Harvey Jacobs Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Gamber Rd, Finksburg, MD 21048 Phone: 410-861-8100 Fax: 410-861-8054 |
Dr. Robin Elaine-plesset Katcoff, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2025 Suffolk Rd, Finksburg, MD 21048 Phone: 410-526-1055 Fax: 410-526-5211 |
Dr. Raimon Cary Iv, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2027 Suffolk Rd Ste 4, Finksburg, MD 21048 Phone: 410-526-1055 Fax: 410-526-5211 |
Mrs. Heidi Leigh Pirozzi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Gamber Rd, Suite 2, Finksburg, MD 21048 Phone: 410-861-8100 Fax: 410-861-8054 |
News Archive
Members of a Syracuse University research team have shown that an obscure phenomenon called stochastic resonance (SR) can improve the clarity of signals in systems such as radar, sonar and even radiography, used in medical clinics to detect signs of breast cancer. It does this by adding carefully selected noise to the system.
Russian researchers from the Moscow Institute of Physics and Technology, the Institute of Cell Biophysics, and elsewhere have shown an antioxidant compound known as peroxiredoxin to be effective in treating kidney injury in mice.
Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that new data from the PROTECT II study will be presented by William O'Neill, M.D., executive dean for clinical affairs at the University of Miami Miller School of Medicine, and principal investigator for the PROTECT II study, during the late-breaking clinical trials session at the Society for Cardiovascular Angiography and Interventions 2011 Scientific Sessions in Baltimore, Maryland.
Chronic lower-limb edema (CLE) - the permanent accumulation of fluid in the leg - often occurs in elderly people.
› Verified 5 days ago